Abstract
The hormonal therapy (HT) is recommended for postmenopausal women primarily for the relief of vasomotor symptoms, treatment of vaginal atrophy, and prevention of osteoporosis. Despite these important benefits, only 35% to 40% of the women ever start HT, and many do not continue it. The reasons for discontinuation include resumption of bleeding, perceived risks of breast cancer, unacceptable side effects and the belief that treatment is no longer necessary. As a result, there is an increasing interest in the use of plant-derived estrogens, also known as phytoestrogens, which seem to be very promising. Isoflavones is the most investigated subgroup of phytoestrogens. They are attenuated estrogens and behave both in vivo and in vitro as agonists and antagonists. The highest concentrations of isoflavones are found primarily in soy beans. In this study, the effects of soy isoflavones on postmenopausal women were reviewed.
Keywords: Soy isoflavone, postmenopausal women, clinical review
Current Drug Therapy
Title: The Effects of Soy Isoflavones in Postmenopausal Women: Clinical Review
Volume: 1 Issue: 1
Author(s): Eliana A P. Nahas and Jorge Nahas-Neto
Affiliation:
Keywords: Soy isoflavone, postmenopausal women, clinical review
Abstract: The hormonal therapy (HT) is recommended for postmenopausal women primarily for the relief of vasomotor symptoms, treatment of vaginal atrophy, and prevention of osteoporosis. Despite these important benefits, only 35% to 40% of the women ever start HT, and many do not continue it. The reasons for discontinuation include resumption of bleeding, perceived risks of breast cancer, unacceptable side effects and the belief that treatment is no longer necessary. As a result, there is an increasing interest in the use of plant-derived estrogens, also known as phytoestrogens, which seem to be very promising. Isoflavones is the most investigated subgroup of phytoestrogens. They are attenuated estrogens and behave both in vivo and in vitro as agonists and antagonists. The highest concentrations of isoflavones are found primarily in soy beans. In this study, the effects of soy isoflavones on postmenopausal women were reviewed.
Export Options
About this article
Cite this article as:
Nahas A P. Eliana and Nahas-Neto Jorge, The Effects of Soy Isoflavones in Postmenopausal Women: Clinical Review, Current Drug Therapy 2006; 1 (1) . https://dx.doi.org/10.2174/157488506775268533
DOI https://dx.doi.org/10.2174/157488506775268533 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Possible Protecting Role of TNF-α in Kainic Acid-induced Neurotoxicity Via Down-Regulation of NFκB Signaling Pathway
Current Alzheimer Research Natural Compounds and Drug Discovery: Can Cnidarian Venom Play a Role?
Central Nervous System Agents in Medicinal Chemistry Targeted Taxane Delivery Systems: Recent Advances
Drug Delivery Letters Synthesis of 2-substituted Furo[3,2-b]pyridines Under Pd/C-Cu Catalysis Assisted by Ultrasound: Their Evaluation as Potential Cytotoxic Agents
Anti-Cancer Agents in Medicinal Chemistry Introduction: P2 Receptors
Current Topics in Medicinal Chemistry Insulin-like Growth Factor: Current Concepts and New Developments in Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Heme Oxygenase-1 in Tumor Biology and Therapy
Current Drug Targets Free Radicals and Antioxidants: How to Reestablish Redox Homeostasis in Chronic Diseases?
Current Medicinal Chemistry Patents on Nanoparticulate Drug Delivery Systems - A Review
Recent Patents on Drug Delivery & Formulation The Pharmaceutical Potential of Histone Deacetylase Inhibitors
Current Pharmaceutical Design Perspectives Offered by Single-Domain Antibodies in Clinical Diagnostic of Pediatric Tumors
Current Medicinal Chemistry A Comprehensive Review on Ethnomedicinal, Pharmacological and Phytochemical Basis of Anticancer Medicinal Plants of Pakistan
Current Cancer Drug Targets Biologic Agents for Treatment of Rheumatoid Arthritis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Physiology and Pharmacology of the Vanilloid Receptor
Current Neuropharmacology Effects of Specific Cyclooxygenase-2 Inhibitors on Carcinogenesis
Medicinal Chemistry Reviews - Online (Discontinued) Caveats Regarding the Use of IL-10 and IL-10 Antagonist as Immunotherapeutic Factors
Letters in Drug Design & Discovery Pharmacokinetic and Pharmacodynamic Variability: A Daunting Challenge in Drug Therapy
Current Drug Metabolism Characterization of YY1 OPB Peptide for its Anticancer Activity
Current Cancer Drug Targets The proNGF-p75NTR-Sortilin Signalling Complex as New Target for the Therapeutic Treatment of Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Multimodal Optical, X-Ray CT, and SPECT Imaging of a Mouse Model of Breast Cancer Lung Metastasis
Current Molecular Medicine